TransDigm Group Incorporated: Stifel cuts to Hold from Buy; cuts target price to $1405 from $1525
TDG•Related News
BioCryst Pharmaceuticals, - Cash, Cash Equivalents, Restricted Cash And Investments $354 Million At June 30, 2026
BCRX•
Beamr integrates NVIDIA Video Super Resolution into live sports, broadcast workflows
BMR•
Flutter Board Announces CEO Transition
FLUT•
McDonald's <MCD.N>: Bernstein cuts target price to $295 from $310
MCD•
Medline Reports Second Quarter And First Six Months 2026 Results
MDLN•